Abstract:Abstract Context With the aging of the population and projected increase in osteoporotic fractures coupled with the declining use of osteoporosis medications, there is a compelling need for new approaches to treat osteoporosis. Given that age-related osteoporosis generally coexists with multiple other comorbidities (e.g., atherosclerosis, diabetes, frailty) that share aging as the leading risk factor, there is growing interest in the “Geroscience Hypothesis,” which posits that manipulation of fundamental aging mechanisms will delay the appearance or severity of multiple chronic diseases because these diseases share aging as the underlying risk factor. In this context, one fundamental aging mechanism that has received considerable attention recently as contributing to multiple age-related morbidities is cellular senescence. This mini-review provides an overview on cellular senescence with a focus on its role in mediating age-related bone loss. Methods This summary is based on the authors’ knowledge of the field supplemented by a PubMed search using the terms “senescence,” “aging,” and “bone.” Results There is compelling evidence from preclinical models and supportive human data demonstrating an increase in senescent cells in the bone microenvironment with aging. These cells produce a proinflammatory secretome that leads to increased bone resorption and decreased bone formation, and approaches that either eliminate senescent cells or impair the production of their proinflammatory secretome have been shown to prevent age-related bone loss in mice. Conclusions Targeting cellular senescence represents a novel therapeutic strategy to prevent not only bone loss but potentially multiple age-related diseases simultaneously.

Cellular senescence as a key factor in osteoporosis: the role of SIRT1

Cellular Senescence: The Driving Force of Musculoskeletal Diseases

Role of Sirtuins in Bone Biology: Potential Implications for Novel Therapeutic Strategies for Osteoporosis.

Sirt1: An Increasingly Interesting Molecule with a Potential Role in Bone Metabolism and Osteoporosis

Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis

Sirtuins mediate mitochondrial quality control mechanisms: a novel therapeutic target for osteoporosis

The Potential Role and Therapeutic Relevance of Cellular Senescence in Skeletal Pathophysiology.

Skeletal Aging and Osteoporosis: Cellular Senescence and Beyond

Cellular senescence in skeletal disease: mechanisms and treatment

Targeting Cell Senescence for the Treatment of Age-Related Bone Loss

Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics

Sirt3 mediates the benefits of exercise on bone in aged mice

Senescent Cells: A Therapeutic Target for Osteoporosis

Regulation of SIRT1 in aging: Roles in mitochondrial function and biogenesis

Sirtuins: exploring next-gen therapeutics in the pathogenesis osteoporosis and associated diseases

Exploring cellular senescence in the musculoskeletal system: any insights for biomarkers discovery?

SIRT3: A Potential Target of Different Types of Osteoporosis

The role of cellular senescence in diabetes mellitus and osteoporosis: molecular pathways and potential interventions

SIRT1 Signaling Pathways in Sarcopenia: Novel Mechanisms and Potential Therapeutic Targets

Senescence of skeletal stem cells and their contribution to age-related bone loss

SIRT2 Deficiency Prevents Age-Related Bone Loss in Rats by Inhibiting Osteoclastogenesis.